Managing HER2 and TROP2 ADC Adverse Events: Advanced Practice Providers Case Discussions Highlighting the Critical Roles in Patient Care

This educational symposium focuses on best practices for identifying and managing adverse events associated with HER2- and TROP2-targeted antibody-drug conjugates (ADCs) used in treating solid tumors. The activity uses case discussions to highlight the critical roles advanced practice providers play in patient care and monitoring of treatment-related adverse events.